News
(UroToday.com) The 2025 AUA annual meeting featured a kidney cancer session and a presentation by Dr. Kazutaka Nakamura discussing a comparison of clinical outcomes between cabozantinib + nivolumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback